iShares U.S. Pharmaceuticals ETF Rating $66.56 +0.10 (+0.15%) (As of 04:45 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.61Holdings in IHE have an aggregate rating of Moderate Buy based on 322 analyst ratings issued in the past year covering 38 companies (99.8% of the portfolio).IHE Aggregate Price Target$66.56High Prediction$66.56Average Prediction$66.56Low Prediction$66.56Holdings in IHE have an aggregate price target of $66.56 and a range of $66.56 to $66.56 covering 38 companies (99.8% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings21.06%JNJJohnson & Johnson$145.85+0.4%4.9129 of 5 stars2.50$174.73 19.8%1420.25%LLYEli Lilly and Company$795.67-0.1%4.997 of 5 stars2.81$1,002.22 26.0%215.61%BMYBristol-Myers Squibb$57.76+0.3%4.7113 of 5 stars2.25$55.64 -3.7%205.24%VTRSViatris$12.40-0.7%2.6366 of 5 stars2.00$13.67 10.2%3News CoverageGap Down4.56%CTLTCatalent$63.482.6097 of 5 stars2.00$63.40 -0.1%74.35%ZTSZoetis$164.70+0.3%4.6054 of 5 stars3.09$215.22 30.7%114.20%MRKMerck & Co., Inc.$99.45+0.1%4.9911 of 5 stars2.71$127.13 27.8%214.08%PFEPfizer$26.74+0.1%4.9734 of 5 stars2.47$32.14 20.2%17Analyst Revision4.07%RPRXRoyalty Pharma$25.23-0.1%4.6655 of 5 stars2.83$41.67 65.1%6Positive News3.37%ITCIIntra-Cellular Therapies$85.24+1.5%4.0886 of 5 stars2.85$97.23 14.1%13Positive News3.01%JAZZJazz Pharmaceuticals$123.73-0.4%4.85 of 5 stars2.87$177.00 43.1%152.57%ELANElanco Animal Health$11.88+0.2%3.8194 of 5 stars2.25$16.71 40.7%82.23%CORTCorcept Therapeutics$52.17+2.5%4.8811 of 5 stars3.00$65.25 25.1%5Analyst Revision1.67%PBHPrestige Consumer Healthcare$78.75+0.2%3.8443 of 5 stars2.50$85.25 8.3%4Positive News1.62%AXSMAxsome Therapeutics$87.01+0.1%4.7306 of 5 stars3.00$125.93 44.7%141.57%OGNOrganon & Co.$14.73+0.2%4.8095 of 5 stars2.50$21.33 44.8%41.54%PRGOPerrigo$25.64-0.1%4.9919 of 5 stars2.75$37.00 44.3%4Positive News0.86%LGNDLigand Pharmaceuticals$113.38-0.4%4.9889 of 5 stars3.00$147.00 29.7%6Analyst Forecast0.82%SUPNSupernus Pharmaceuticals$35.60+0.0%2.2851 of 5 stars2.50$36.00 1.1%20.71%TARSTarsus Pharmaceuticals$54.04-0.7%0.5157 of 5 stars3.00$54.20 0.3%7News Coverage0.71%EWTXEdgewise Therapeutics$29.62-1.2%2.5694 of 5 stars3.00$43.17 45.7%6Positive News0.67%AMPHAmphastar Pharmaceuticals$38.27-2.2%4.8633 of 5 stars2.50$60.33 57.7%4News CoveragePositive News0.65%ARVNArvinas$18.73+4.1%1.8598 of 5 stars2.93$63.50 239.0%150.51%HRMYHarmony Biosciences$34.06-2.5%4.8066 of 5 stars2.60$49.80 46.2%100.48%AMRXAmneal Pharmaceuticals$7.85+0.8%2.8717 of 5 stars2.80$10.00 27.4%5Options Volume0.43%INVAInnoviva$17.78-0.1%2.3309 of 5 stars3.0010.40%COLLCollegium Pharmaceutical$29.06-0.3%3.7269 of 5 stars2.60$42.60 46.6%50.39%ANIPANI Pharmaceuticals$54.16-0.1%4.8538 of 5 stars3.00$77.71 43.5%8Positive News0.36%PCRXPacira BioSciences$19.47+1.4%3.0737 of 5 stars2.20$23.50 20.7%100.35%NMRANeumora Therapeutics$10.63-4.4%2.7294 of 5 stars2.83$23.40 120.1%6Options VolumeNews Coverage0.32%PLRXPliant Therapeutics$13.49+1.1%3.7459 of 5 stars3.13$40.50 200.2%8News Coverage0.29%ELVNEnliven Therapeutics$23.15-1.2%2.847 of 5 stars3.20$38.25 65.2%5Positive News0.22%MNMDMind Medicine (MindMed)$7.32+3.4%3.0003 of 5 stars3.25$26.75 265.4%12News Coverage0.19%NUVBNuvation Bio$2.82+5.6%2.0083 of 5 stars3.00$6.60 134.0%5Analyst ForecastNews Coverage0.14%TBPHTheravance Biopharma$9.85+0.6%2.4239 of 5 stars2.40$13.75 39.6%50.13%PHATPhathom Pharmaceuticals$7.50-1.4%2.8382 of 5 stars2.75$23.00 206.7%40.11%RVNCRevance Therapeutics$3.08+0.3%3.6353 of 5 stars2.11$8.39 172.3%9Analyst Forecast0.05%SAVACassava Sciences$2.34-2.9%4.5312 of 5 stars2.50$111.50 4,665.0%2 This page (NYSEARCA:IHE) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IHE Stock Alerts